Association of vitamin D with risk of type 2 diabetes: A Mendelian randomisation study in European and Chinese adults

Background Observational studies have reported that higher plasma 25-hydroxyvitamin D (25[OH]D) concentrations are associated with lower risks of diabetes, but it is unclear if these associations are causal. The aim of this study was to test the relevance of 25(OH)D for type 2 diabetes using genetically instrumented differences in plasma 25(OH)D concentrations. Methods and findings Data were available on four 25(OH)D single nucleotide polymorphisms (SNPs; n = 82,464), plasma 25(OH)D concentrations (n = 13,565), and cases with diabetes (n = 5,565) in the China Kadoorie Biobank (CKB). The effects on risk of diabetes were assessed by a genetic score using two 25(OH)D synthesis SNPs (DHCR7-rs12785878 and CYP2R1-rs10741657), with and without the addition of SNPs affecting the transport (GC/DBP-rs2282679) and catabolism (CYP24A1-rs6013897) of 25(OH)D. The CKB results were combined in a meta-analysis of 10 studies for the 2 synthesis SNPs (n = 58,312 cases) and 7 studies for all 4 SNPs (n = 32,796 cases). Mean (SD) 25(OH)D concentration was 62 (20) nmol/l in CKB, and the per allele effects of genetic scores on 25(OH)D were 2.87 (SE 0.39) for the synthesis SNPs and 3.54 (SE 0.32) for all SNPs. A 25-nmol/l higher biochemically measured 25(OH)D was associated with a 9% (95% CI: 0%–18%) lower risk of diabetes in CKB. In a meta-analysis of all studies, a 25-nmol/l higher genetically instrumented 25(OH)D concentration was associated with a 14% (95% CI: 3%–23%) lower risk of diabetes (p = 0.01) using the 2 synthesis SNPs. An equivalent difference in 25(OH)D using a genetic score with 4 SNPs was not significantly associated with diabetes (odds ratio 8%, 95% CI: −1% to 16%, lower risk, p = 0.07), but had some evidence of pleiotropy. A limitation of the meta-analysis was the access only to study level rather than individual level data. Conclusions The concordant risks of diabetes for biochemically measured and genetically instrumented differences in 25(OH)D using synthesis SNPs provide evidence for a causal effect of higher 25(OH)D for prevention of diabetes.

[1]  K. Jones,et al.  Letter to the Editor: The Effect of Genetic Factors on the Response to Vitamin D Supplementation May Be Mediated by Vitamin D-Binding Protein Concentrations. , 2017, The Journal of clinical endocrinology and metabolism.

[2]  Tanya M. Teslovich,et al.  An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans , 2017, Diabetes.

[3]  Olena O Yavorska,et al.  MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data , 2017, International journal of epidemiology.

[4]  J. Emberson,et al.  Optimum dose of vitamin D for disease prevention in older people: BEST-D trial of vitamin D in primary care , 2016, Osteoporosis International.

[5]  S. Sharp,et al.  Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study , 2015, The lancet. Diabetes & endocrinology.

[6]  N. Wareham,et al.  Epidemiology of diabetes , 2014, Medicine.

[7]  J. Ware,et al.  Rationale and Design of the Vitamin D and Type 2 Diabetes (D2d) Study: A Diabetes Prevention Trial , 2014, Diabetes Care.

[8]  J. Ilonen,et al.  An Increase in Serum 25-Hydroxyvitamin D Concentrations Preceded a Plateau in Type 1 Diabetes Incidence in Finnish Children , 2014, The Journal of clinical endocrinology and metabolism.

[9]  Ross M. Fraser,et al.  Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study , 2014, The lancet. Diabetes & endocrinology.

[10]  C. Ling,et al.  β-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment. , 2014, The Journal of clinical endocrinology and metabolism.

[11]  S. Bojesen,et al.  Vitamin D concentration, obesity, and risk of diabetes: a mendelian randomisation study. , 2014, The lancet. Diabetes & endocrinology.

[12]  Ishir Bhan,et al.  Vitamin D-binding protein and vitamin D status of black Americans and white Americans. , 2013, The New England journal of medicine.

[13]  M. Schulze,et al.  Plasma 25-hydroxyvitamin D and its genetic determinants in relation to incident type 2 diabetes: a prospective case-cohort study , 2013, European Journal of Epidemiology.

[14]  S. Thompson,et al.  Use of allele scores as instrumental variables for Mendelian randomization , 2013, International journal of epidemiology.

[15]  J. Manson,et al.  Blood 25-Hydroxy Vitamin D Levels and Incident Type 2 Diabetes , 2013, Diabetes Care.

[16]  S. Bojesen,et al.  Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysis. , 2013, Clinical chemistry.

[17]  Glenville Jones,et al.  25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D. , 2012, Archives of biochemistry and biophysics.

[18]  Tom Wilsgaard,et al.  Polymorphisms Related to the Serum 25-Hydroxyvitamin D Level and Risk of Myocardial Infarction, Diabetes, Cancer and Mortality. The Tromsø Study , 2012, PloS one.

[19]  Diane J. Berry,et al.  Evaluation of Genetic Markers as Instruments for Mendelian Randomization Studies on Vitamin D , 2012, PloS one.

[20]  R. Luben,et al.  Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies , 2012, Diabetologia.

[21]  R. Collins,et al.  China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. , 2011, International journal of epidemiology.

[22]  F. Hu,et al.  Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. , 2011, The American journal of clinical nutrition.

[23]  S. Salekzamani,et al.  Daily consumption of vitamin D- or vitamin D + calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial. , 2011, The American journal of clinical nutrition.

[24]  Daniel L. Koller,et al.  Common genetic determinants of vitamin D insufficiency: a genome-wide association study , 2010, The Lancet.

[25]  R. Jorde,et al.  No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year , 2010, Journal of internal medicine.

[26]  William Wheeler,et al.  Genome-wide association study of circulating vitamin D levels , 2010, Human molecular genetics.

[27]  A. Avenell,et al.  Vitamin D supplementation and type 2 diabetes: a substudy of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438). , 2009, Age and ageing.

[28]  O. Franco,et al.  Plasma 25-Hydroxyvitamin D Concentration and Metabolic Syndrome Among Middle-Aged and Elderly Chinese Individuals , 2009, Diabetes Care.

[29]  M. Holick.  Vitamin D deficiency. , 2007, The New England journal of medicine.

[30]  Bess Dawson-Hughes,et al.  The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. , 2007, The Journal of clinical endocrinology and metabolism.

[31]  Jianhua Zhang,et al.  Identification of a Region in the Vitamin D-binding Protein that Mediates Its C5a Chemotactic Cofactor Function* , 2004, Journal of Biological Chemistry.

[32]  M. Holick.  Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. , 2004, The American journal of clinical nutrition.

[33]  M. Plummer.  Improved estimates of floating absolute risk , 2004, Statistics in medicine.

[34]  Roberto Dominguez,et al.  Crystal structures of the vitamin D-binding protein and its complex with actin: Structural basis of the actin-scavenger system , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. Sar,et al.  Effect of 1,25 Dihydroxyvitamin D3 on Insulin Secretion , 1981, Diabetes.

[36]  B. Kestenbaum,et al.  Calcium plus vitamin D supplementation and the risk of incident diabetes mellitus in the Women ’ s Health Initiative , 2008 .

[37]  F. Hole.  The Europeans , 1983, Nature.